William Stilley

William Stilley is a seasoned executive in the biotechnology and pharmaceutical industries, currently serving as the Chief Executive Officer at Adovate since January 2023, focusing on developing innovative adenosine receptor-targeting molecules. Stilley is also a Board Member and Chair of the Audit Committee at Avalon Globocare Corp, providing leadership in immune cell therapy and diagnostic solutions. Previously, Stilley co-founded and led Purnovate, Inc. and Adial Pharmaceuticals, where significant progress was made in drug development for addiction disorders and chronic conditions. Stilley holds board positions in various organizations, including the Virginia Biotechnology Association, while also sharing expertise as a former visiting lecturer at the Darden School of Business. Educational background includes an M.B.A. from the University of Virginia Darden School of Business and a Bachelor of Commerce from UVA McIntire School of Commerce.